Literature DB >> 11395250

High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.

Y Iwadate1, J Mizoe, Y Osaka, A Yamaura, H Tsujii.   

Abstract

PURPOSE: A mutation in the p53 gene is believed to play an important role in the radioresistance of many cancer cell lines. We studied cytotoxic effects of high linear energy transfer (LET) carbon beams on glioma cell lines with either mutant or wild-type p53. METHODS AND MATERIALS: Cell lines U-87 and U-138 expressing wild-type p53 and U-251 and U-373 expressing mutant p53 were used. These cells were irradiated with 290 MeV/u carbon beams generated by the Heavy Ion Medical Accelerator in the National Institute of Radiologic Science or X-rays. A standard colony-forming assay and flow cytometric detection of apoptosis were performed. Cell cycle progression and the expression of p53, p21, and bax proteins were examined.
RESULTS: High LET carbon radiation was more cytotoxic than low LET X-ray treatment against glioma cells. The effects of the carbon beams were not dependent on the p53 gene status but were reduced by G(1) arrest, which was independent of p21 expression. The expression of bax remained unchanged in all four cell lines.
CONCLUSION: These results indicate that high LET charged particle radiation can induce cell death in glioma cells more effectively than X-rays and that cell death other than p53-dependent apoptosis may participate in the cytotoxicity of heavy charged particles. Thus, it might prove to be an effective alternative radiotherapy for patients with gliomas harboring mutated p53 gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395250     DOI: 10.1016/s0360-3016(01)01514-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation.

Authors:  Bing Liu; Hong Zhang; Xiaohong Luo; Yi Xie; Jifang Hao; Qingming Zhou; Xin Duan; Yanling Wang; Weiping Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-16       Impact factor: 4.553

2.  Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation.

Authors:  Gérald Bertrand; Mira Maalouf; Antony Boivin; Priscillia Battiston-Montagne; Michael Beuve; Antonin Levy; Patrice Jalade; Claudia Fournier; Dominique Ardail; Nicolas Magné; Gersende Alphonse; Claire Rodriguez-Lafrasse
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

3.  Integrin-based meningioma cell migration is promoted by photon but not by carbon-ion irradiation.

Authors:  Florian Simon; Jan-Oliver Dittmar; Stephan Brons; Lena Orschiedt; Steffi Urbschat; Klaus-Josef Weber; Jürgen Debus; Stephanie E Combs; Stefan Rieken
Journal:  Strahlenther Onkol       Date:  2014-12-02       Impact factor: 3.621

4.  Effect of exogenous wild-type p53 on melanoma cell death pathways induced by irradiation at different linear energy transfer.

Authors:  Feng-Ling Min; Hong Zhang; Wen-Jian Li; Qing-Xiang Gao; Guang-Ming Zhou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Sep-Oct       Impact factor: 2.416

Review 5.  Recent advancements in multimodality treatment of gliomas.

Authors:  Mersiha Hadziahmetovic; Katsuyuki Shirai; Arnab Chakravarti
Journal:  Future Oncol       Date:  2011-10       Impact factor: 3.404

6.  Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.

Authors:  Stephanie E Combs; Meinhard Kieser; Stefan Rieken; Daniel Habermehl; Oliver Jäkel; Thomas Haberer; Anna Nikoghosyan; Renate Haselmann; Andreas Unterberg; Wolfgang Wick; Jürgen Debus
Journal:  BMC Cancer       Date:  2010-09-06       Impact factor: 4.430

7.  Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.

Authors:  Stephanie E Combs; Lutz Edler; Iris Burkholder; Stefan Rieken; Daniel Habermehl; Oliver Jäkel; Thomas Haberer; Andreas Unterberg; Wolfgang Wick; Jürgen Debus; Renate Haselmann
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

8.  Changes in bone volume after irradiation with carbon ions.

Authors:  Masahiko Sawajiri; Jun'etsu Mizoe
Journal:  Radiat Environ Biophys       Date:  2003-05-24       Impact factor: 1.925

9.  Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.

Authors:  M Kano; K Matsushita; B Rahmutulla; S Yamada; H Shimada; S Kubo; T Hiwasa; H Matsubara; F Nomura
Journal:  Gene Ther       Date:  2015-08-04       Impact factor: 5.250

10.  Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma.

Authors:  Yusei Fujita; Itsuro Kato; Soichi Iwai; Koji Ono; Minoru Suzuki; Yoshinori Sakurai; Ken Ohnishi; Takeo Ohnishi; Yoshiaki Yura
Journal:  Radiat Oncol       Date:  2009-12-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.